person · Reporting owner

Peterson Todd C.

Disclosed activity across 1 company

Tapewire entity: 61585
SEC CIK: 0001791061

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Armata Pharmaceuticals, Inc.ARMP · Entity 6329	Director	March 09, 2026	March 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Armata Pharmaceuticals, Inc.

Report date March 09, 2026 · Filed March 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.61 · Expires 2036-03-09	Direct	25,640	Reported balance After 2026-03-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-03-09 · Grant · Acquired 25,640 · Balance 25,640 F1: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 09, 2026 Filed Mar 12, 2026 01:16 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	25,640	$0.00 Strike: $11.61	$0.00	Disclosure SEC source: 0001104659-26-026585 · tm268588-3_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,640 Underlying: Common Stock · 25,640 shares Expires 2036-03-09 F1 · derivative.exercise_date: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date. Read SEC document
February 05, 2025 Filed Feb 7, 2025 21:20 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	54,343	$0.00 Strike: $2.04	$0.00	Disclosure SEC source: 0001104659-25-010566 · tm255864-7_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,343 Underlying: Common Stock · 54,343 shares Expires 2035-02-05 F1 · derivative.exercise_date: The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date. Read SEC document
March 14, 2024 Filed Mar 19, 2024 00:03 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	54,343	$0.00 Strike: $3.38	$0.00	Disclosure SEC source: 0001104659-24-035729 · tm249071-8_4seq1.xml · derivative · entry 2 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,009 Underlying: Common Stock · 54,343 shares Expires 2034-03-14 F2 · derivative.exercise_date: The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date. Read SEC document
March 14, 2024 Filed Mar 19, 2024 00:03 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	39,666	$0.00 Strike: $3.38	$0.00	Disclosure SEC source: 0001104659-24-035729 · tm249071-8_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,666 Underlying: Common Stock · 39,666 shares Expires 2034-03-14 F1 · derivative.exercise_date: The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024. Read SEC document
December 21, 2023 Filed Dec 27, 2023 02:55 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	10,461	$0.00 Strike: $2.39	$0.00	Disclosure SEC source: 0001104659-23-129370 · tm2333426-3_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,461 Underlying: Common Stock · 10,461 shares Expires 2033-12-21 F1 · derivative.exercise_date: The stock option vests immediately prior to the Company's 2024 annual shareholders meeting. Read SEC document
April 13, 2022 Filed Apr 15, 2022 19:56 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Options (Right to Buy) · Derivative	33,000	$0.00 Strike: $5.11	$0.00	Disclosure SEC source: 0001104659-22-046459 · tm2212851-9_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2032-04-13 F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant. Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:26 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Option (Right to Buy) · Derivative	28,000	$0.00 Strike: $4.29	$0.00	Disclosure SEC source: 0001104659-21-078788 · tm2119245-4_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2031-06-07 F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant. Read SEC document
December 08, 2020 Filed Dec 9, 2020 21:11 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Option (Right to Buy) · Derivative	23,000	$0.00 Strike: $3.15	$0.00	Disclosure SEC source: 0001104659-20-133642 · tm2038059-9_4seq1.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2030-12-08 F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant. Read SEC document
October 10, 2019 Filed Oct 15, 2019 20:06 UTC	Armata Pharmaceuticals, Inc. ARMP · Entity 6329	GrantStock Option (Right to Buy) · Derivative	27,383	$0.00 Strike: $3.77	$0.00	Disclosure SEC source: 0001104659-19-054141 · tv531072_4.xml · derivative · entry 1 Peterson Todd C. · CIK 0001791061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,383 Underlying: Common Stock · 27,383 shares Expires 2029-10-10 F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.